Induced Pluripotent (iPSC) and Mesenchymal (MSC) Stem Cells for In Vitro Disease Modeling and Regenerative Medicine
International Journal of Molecular Sciences · 11.06.2025 · 26 (12) · 5617
DOI: 10.3390/ijms26125617 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.06.2025. Verfasst von Egor Panferov und 6 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine Research Center, Sirius University of Science and Technology, Olympic Avenue, 1, 354340 Sochi, Russia. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Mesenchymal Stem Cells, Regenerative Medicine. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 407 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: state program of the «Sirius» Federal Territory «Scientific and technological development of the «Sirius» Federal Territory», Sirius Federal Territory Scientific and technological development of the Sirius Federal Territory.
Abstract (Originalsprache)
In vitro disease modeling can be used both for understanding the development of pathology and for screening various therapies, such as gene therapies. This approach decreases costs, shortens research timelines, reduces animal testing, and may be more accurate in replicating the disease phenotype compared to animal models. This review focuses on the two types of stem cells: induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs), which can be used for this purpose. Special attention is given to the impact of the isolation source and the variable expression of certain phenotypic markers on the differentiation capacity of these cells. Both similarities and critical differences between iPSCs and MSCs, as well as the outcomes of past and ongoing clinical trials, are discussed in order to gain insight and understanding as to which of these two cell types can be more suitable for the particular biomedical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Translational Medicine Research Center, Sirius University of Science and Technology, Olympic Avenue, 1, 354340 Sochi, Russia.
ORCID-Profile: Egor Panferov, Vasiliy Reshetnikov, Anastasia Ryapolova, Roman Ivanov, Alexander Karabelsky, Ekaterina Minskaia
Förderung
- state program of the «Sirius» Federal Territory «Scientific and technological development of the «Sirius» Federal Territory»
- Sirius Federal Territory Scientific and technological development of the Sirius Federal Territory
Zitieren
APA
Panferov, E., Dodina, M., Reshetnikov, V., Ryapolova, A., Ivanov, R., Karabelsky, A., & Minskaia, E. (2025). Induced Pluripotent (iPSC) and Mesenchymal (MSC) Stem Cells for In Vitro Disease Modeling and Regenerative Medicine. International Journal of Molecular Sciences, 26(12), 5617. https://doi.org/10.3390/ijms26125617
Vancouver
Panferov E, Dodina M, Reshetnikov V, Ryapolova A, Ivanov R, Karabelsky A, et al. Induced Pluripotent (iPSC) and Mesenchymal (MSC) Stem Cells for In Vitro Disease Modeling and Regenerative Medicine. International Journal of Molecular Sciences. 2025;26(12):5617. doi:10.3390/ijms26125617
BibTeX
@article{Panferov2025,
author = {Panferov, Egor and Dodina, Maria and Reshetnikov, Vasiliy and Ryapolova, Anastasia and Ivanov, Roman and Karabelsky, Alexander and Minskaia, Ekaterina},
title = {Induced Pluripotent (iPSC) and Mesenchymal (MSC) Stem Cells for In Vitro Disease Modeling and Regenerative Medicine},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {12},
pages = {5617},
doi = {10.3390/ijms26125617}
}
EUVIMED